Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Cost-Effectiveness, High Demand and Patent Exclusivity to Drive the Biosimilars Market

Mordor Intelligence
Posted on: 30 Sep 16

HYDERABAD, India, September 30, 2016 /PRNewswire/ --

Mordor Intelligence announces the publication of their research report on the biosimilars market. The report titled, "Global Biosimilars Market - Growth, Trends and Forecast," discusses the current landscape and outlook of the market.

The biosimilars market accounted for a value of USD 2.8 billion in 2015 and is estimated at USD 3.3 million in 2016. The market is expected to reach USD 7.3 billion by 2021, projecting a CAGR of 17.42% during the forecast period. The report is an amalgamation of the current market scenario, its prospects and forces driving and restraining the market growth. The report highlights the North American, European, Asia-Pacific, and Latin American and Middle East & African markets.

The high demand for biosimilars for cost-effectiveness, increasing disease burden, drugs going off-patent, increasing patient access to biologics therapy, increasing research & development for biosimilars and high demand for addressing different therapeutic conditions are the key factors propelling the growth of the market.

Browse Related Report Here

The biosimilars market has been segmented based on type of product, application and geography. The segmentation based on products has been segmented into recombinant glycosylated protein, recombinant non-glycosylated protein and peptides. The various drugs such as Humira, Enbrel, Lantus and other drugs losing patent exclusivity in different regions across the world will lead to entry of biosimilars. This will be a big opportunity for players in biosimilars market.

The market is expected to grow with the highest CAGR in Asia-Pacific region. The market in Europe and North America is also expected to grow at a steady growth rate.

The leading players in this market are Hospira, Roche, Sandoz, Teva Pharmaceuticals, Amgen, Biocon, Dr. Reddy's Laboratories. Mylan and Merck.

About Mordor Intelligence: 

Mordor Intelligence is a global market research and consulting firm. Our focus is to provide research insights to facilitate business success. Our research expertise covers niche segments under Agriculture, Healthcare, ICT, Chemicals, Manufacturing, Logistics, Electronics and Automotive, among others. We believe in data, and we provide solutions through it. Optimum solutions and goal-oriented strategies define our endeavors and make us the preferred choice for clients.

For information regarding permissions and sales, please contact:

Media Contact:
Madan Gopal
AVP - Marketing & Strategy
Direct Line: +1 617-765-2493

For more information:

Editor's Details

Mike Wood

Last updated on: 30/09/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.